Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Aurora Cannabis

Canopy Growth

Cronos Group

MGC Pharmaceuticals Ltd (LON:MXC) shares, fresh from their London debut, have been caught up in a Reddit-led rush into cannabis-focused companies. Looking for their next stocks to buy after lighting fires under GameStop Corp (NYSE:GME) and AMC Entertainment (NYSE:AMC) in recent weeks, retail investors who read Reddit's WallStreetBets and use RobinHood and other trading apps seem to have got hip to the momentum in the sector and began piling in overnight.

Cannabis stocks sent higher in new Reddit investor rally

OrganiGram Holdings Inc.

SNDL Inc.

Pot stocks are popular with the Reddit crowd right now, and there are some fundamental reasons behind rising share prices, too.

Why Sundial Growers Stock Gained Again, but Tilray and OrganiGram Holdings Dropped Today

Reddit users looking for the next short squeeze have eyed TLRY stock, the second-most shorted Robinhood company. Here's what could come next.

TLRY Stock Short Squeeze Alert: Is Tilray the Next GameStop?

MGC Pharmaceuticals Ltd (LON:MXC) shares, fresh from their London debut, have been caught up in a Reddit-led rush into cannabis-focused stocks. Looking for their next stocks to buy after lighting fires under GameStop Corp (NYSE:GME) and AMC Entertainment (NYSE:AMC) in recent weeks, traders who read Reddit's WallStreetBets and use RobinHood and other trading apps seem to have got hip to the momentum in the sector and began piling in overnight.

MGC, Tilray and Namaste soar as Reddit-inspired traders send cannabis stocks higher

The stock price of Tilray Inc (NASDAQ: TLRY) is trading at over 10% pre-market as of 7:12 AM ET. This is why it happened.

TLRY Stock Price Increases Over 10% Pre-Market: Why It Happened

Aphria

The group of cannabis companies are garnering attention from the same WallStreetBets Reddit army that contributed to the epic short squeeze in GameStop last month.

Reddit trader-favored cannabis stocks jump again on Thursday

GrowGeneration Corp

Scotts Miracle-Gro

The marijuana industry looks set to witness growth going forward due to wider adoption, making it prudent to look at names like Scotts Miracle-Gro (SMG), GrowGeneration (GRWG) and Tilray (TLRY)

3 Stocks to Benefit From the Rapid Adoption of Marijuana

Cannabis stocks are surging pre-market amid high interest from retail investors on social media, in particular the Reddit community WallStreetBets. Sundial Growers (NASDAQ:SNDL) is trading 30% higher at $3.83 in the early pre-market session at press time on Thursday.

Sundial, Tilray, Aphria Surge Pre-Market Amid High Retail Investor Interest

Uber

Shares of the marijuana pharma company shot up another 51% Wednesday, following a +44% performance yesterday; Tilray is now up 400% in just the last month alone.

Tilray Bought by the Reddit Crowd, Plus UBER's Q3

Cannabis producer Tilray has seen a rise in short interest in the past week, with 36.6% of its freefloat out on loan, according to estimates from financial analytics firm Ortex on Wednesday.

Short interest in pot stock Tilray surged in past week: Ortex

News of business expansion and optimism on several fronts has sent shares soaring this year.

Here's Why Tilray Stock Rose Again Today

Shares of Canadian cannabis company Tilray Inc. soared 29% Wednesday to extend their prior-day gains, as the same investor group that caused the shares of videogame retailer GameStop Inc. to climb to dizzying heights appeared to have the stock in their crosshairs.

Cannabis Watch: Tilray shares soar 29% as Reddit message board sets sights on cannabis sector

Since we upgraded Tilray on January 6 and reaffirmed our view on January 15, its shares have rallied ~300% in just one month. We believe Tilray shares are overheated in the near-term due to its massive outperformance against Aphria, leading to a 50% merger arbitrage which is highly unusual.

Tilray: Please Take Some Profits

The trio of cannabis companies are garnering attention from the same Reddit army that contributed to the epic short squeeze in GameStop last month.

Cannabis stocks soar as Reddit crowd that spiked GameStop jumps in, Tilray surges 25%

GW Pharmaceuticals

Jazz Pharmaceuticals

Cannabis stocks seem poised to gain on hopes of removal of the federal ban on cannabis products under the new administration.

Cannabis Stocks Rise on Hopes of Federal Legalization in US

Cannabis stocks are all the rage Wednesday morning as investors over on r/WallStreetBets are talking about the profits from the weed plays. The post Cannabis Stocks: Reddit Chatter Lights Up TLRY, APHA, CGC, SNDL and Other Pot Names Today appeared first on InvestorPlace.

Cannabis Stocks: Reddit Chatter Lights Up TLRY, APHA, CGC, SNDL and Other Pot Names Today

Cannabis producers surged on Wednesday as firms and investors turned more optimistic toward marijuana legalization in the US. Pot stocks have thrived in 2021 as Democrats' control of the government boosts the odds of legalization. President Joe Biden indicated during his campaign he would move to decriminalize the drug. Democrats in Congress have echoed such calls and taken additional steps, pushing for the full legalization of cannabis in the US.

Pot stocks rally on renewed hopes for near-term legalization

Lizhi

BondBloxx Bloomberg One Year Target Duration US Treasury ETF

These three fast-going stocks are raising temperatures even during the depths of winter.

3 Hot Stocks to Watch In February

The stock price of Tilray Inc (NASDAQ: TLRY) is trading at over 20% pre-market as of 6:13 AM ET. This is why it happened.

TLRY Stock Price Increases Over 20% Pre-Market: Why It Happened

The company's organic medicine should become available within weeks.

Tilray Strikes Deal to Export Medical Marijuana to the U.K.

MedMen Enterprises Inc.

Cannabis industry stocks soared on Tuesday as industry leaders made groovy predictions about their financial prospects and marijuana legalization in Washington. Shares in Canadian grower Tilray finished up more than 40 percent on Tuesday after Chief executive Brendan Kennedy mused to Bloomberg Television that he now expects more state and possibly a federal legalization within.

Pot stocks soar on renewed hopes of legalization

Cisco Systems

Lyft

Twitter

With Tilray (TLRY) +44% and Canopy (CGC) +12% on the day, the Nasdaq and Russell 2000 managed to climb to fresh all-time highs Tuesday.

Pot Stocks Take Markets Higher; Plus Beats for Cisco, Twitter, Lyft

Tilray's agreement with Grow Pharma to import and distribute medical cannabis products in the United Kingdom is just the latest example of how investors are embracing pot stocks.

Any News Is Good News for Pot Stock Investors. Tilray Shares Are Up More Than 35%.

Grow Pharma said it has struck a deal with cannabis and pharma giant Tilray (NASDAQ:TLRY) to import and distribute the latter's medical cannabis products in the UK. Patients will have access to the products by obtaining prescriptions privately or via the National Health Service (NHS) and Tilray expects to have them available by March this year.

Grow Pharma set to distribute Tilray's medical cannabis products in the UK

Investors in the Canadian pot growers are seeing potential outside the Great White North.

News for Tilray Brands Stock (TLRY)